A Phase I Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
Latest Information Update: 16 Jan 2023
Price :
$35 *
At a glance
- Drugs Everolimus (Primary) ; Ribociclib (Primary)
- Indications Diffuse intrinsic pontine glioma; Glioma
- Focus Adverse reactions; Pharmacokinetics
- 12 Jan 2023 Status changed from active, no longer recruiting to completed.
- 28 Aug 2020 Planned End Date changed from 1 Jan 2022 to 31 Jul 2022.
- 20 Jun 2020 Planned primary completion date changed from 1 Mar 2020 to 1 Jul 2020.